文献速递免疫规划

韩国儿童灭活乙脑疫苗第三剂加强针的免疫原性与安全性

Immunogenicity and safety of the third booster dose of the inactivated Japanese encephalitis vaccine in Korean children: A prospective multicenter study.
PubMed 文献 · Vaccine · 2021-03-10

该前瞻性多中心研究纳入11–13岁、已完成基础免疫并接种过四剂灭活乙脑疫苗的健康韩国儿童,所有受试者接种第三剂加强针。接种前后血清保护率均为100%,中和抗体几何平均滴度(GMT)由139.11升至841.53,呈6.05倍增长,局部耐受性与全身安全性良好,未发生严重不良事件。

要点

  • 接种前后血清保护率均为100%,第三剂加强针免疫原性良好
  • 局部耐受性与全身安全性良好,未报告严重不良事件

核心结论

  • 按现行免疫程序接种第三剂灭活乙脑疫苗加强针,在韩国儿童中安全且具有免疫原性。

研究设计与样本

  • 前瞻性多中心研究,纳入11–13岁、已完成基础免疫并接种四剂灭活乙脑疫苗的健康韩国儿童,所有受试者接种第三剂加强针。
  • 采用蚀斑减少中和试验(PRNT)于接种前及接种后4–6周检测中和抗体滴度,以≥1:10为保护水平。
  • 接种后4周监测局部与全身不良事件。

主要发现

  • 接种前后血清保护率均为100%。
  • 局部耐受性与全身安全性良好,未发生严重不良事件。

关键数值与推荐

  • 韩国灭活乙脑疫苗免疫程序为12–24月龄两剂基础免疫,基础免疫后12个月及6岁、12岁各接种一剂加强针。
  • 中和抗体滴度≥1:10视为具有保护作用。
  • 接种后4–6周评估中和抗体,接种后4周监测不良事件。

临床怎么用

  • 按现行程序在6岁和12岁完成加强接种,可维持高血清保护率并显著提升中和抗体滴度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The immunization schedule for the inactivated Japanese encephalitis (JE) vaccine in Korea is a two-dose primary series at 12-24 months of age and three booster doses at 12 months after primary schedule and at 6 and 12 years of age. The aim of this study was to investigate immunogenicity and safety of the third booster dose of the inactivated JE vaccine, as well as the long-term immunogenicity of the second booster dose in Korean children. Healthy children aged 11-13 years, primed and given four doses of inactivated JE vaccines were included. All subjects received the third booster dose of the JE vaccine. Neutralizing antibody (NTAb) titers were assessed before and 4-6 weeks after vaccination using plaque reduction neutralization test (PRNT), and were considered to be protective at ≥ 1:10. Local and systemic adverse events were monitored for 4 weeks after vaccination. Before and after booster vaccination, all seroprotection rates were 100%. Geometric mean titer (GMT) showed a 6.05-fold increase, from 139.11 (95% CI: 110.76, 174.71) to 841.53 (95% CI, 714.25, 991.50). The local tolerability and systemic safety profiles were favorable, with no serious adverse events. In conclusion, the third booster dose of the inactivated JE vaccine was demonstrated to be safe and immunogenic in Korean children when administered according to the current immunization schedule.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Kwak BO, Kwon YS, Hong YJ, et al. Immunogenicity and safety of the third booster dose of the inactivated Japanese encephalitis vaccine in Korean children: A prospective multicenter study. Vaccine. 2021. PMID: 33712352. doi:10.1016/j.vaccine.2021.02.076

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。